Understanding How Regulators View Internet of Things and Digital Health Technology
A Regulatory Map for Digital Trials
The clinical trial revolution, driven by the Internet of Things (IoT) and Digital Health Technologies (DHTs), is expanding globally. We're seeing a fundamental shift towards continuous, real-world data collection and patient-centric Decentralized Clinical Trials (DCTs). But as these innovations cross borders, how are key regulatory bodies like the FDA, …
Keep reading with a 7-day free trial
Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.